Cover Image

53 Perceptions of HIV remission ("cure") trials and trial intentions among potential participants treated in acute HIV infection

Saved in:

Bibliographic Details
Main Authors:	H. Peay (Author), T. Jupimai (Author), G. Henderson (Author), P. Pongtriang (Author), N. Chomchey (Author), N. Phanuphak (Author), P. Prueksakaew (Author), E. Kroon (Author), J. Ananworanich (Author)
Format:	Book
Published:	Elsevier, 2016-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent
by: Holly L. Peay, et al.
Published: (2015)

Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection
by: Pien van Paassen, et al.
Published: (2022)

HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption
by: Eunice Akinyi Okumu, et al.
Published: (2023)

How do HIV cure trial researchers respond to an embedded social science study?
by: H. Peay, et al.
Published: (2019)

Community participation in HIV cure research: perspectives from Thailand
by: Nittaya Phanuphak, et al.
Published: (2015)

Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
by: Eunice Akinyi Okumu, et al.
Published: (2023)

33 Experiences and expectations of participants completing HIV cure-focused clinical trials
by: J.H. McMahon, et al.
Published: (2017)

HIV cure research: a formidable challenge
by: Jintanat Ananworanich, et al.
Published: (2015)

Factors associated with intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men
by: Nitiya Chomchey, et al.
Published: (2017)

Preferential infection of α4β7+ CD4+ T cells in early acute HIV-1 infection
by: L. McKinnon, et al.
Published: (2019)

OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
by: E. Kroon, et al.
Published: (2016)

Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
by: Michael P. Arnold, et al.
Published: (2015)

57 HIV cure research: a survey of Australian people living with HIV on perspectives, perceived benefits and willingness to participate in trials
by: J. Power, et al.
Published: (2016)

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study
by: Marion Fiorentino, et al.
Published: (2019)

Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviour
by: Nittaya Phanuphak, et al.
Published: (2015)

Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviour
by: Nittaya Phanuphak, et al.
Published: (2015)

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015)

Is there gender bias in HIV cure research? A case study of female representation at the 2015 HIV Persistence Workshop
by: Rowena Johnston, et al.
Published: (2016)

52 How to keep high-risk early-phase HIV cure and long-term remission studies ethical: classifying candidate solutions
by: N. Eyal
Published: (2016)

Motivations, barriers and experiences of participants in an HIV reservoir trial
by: Marie-Angélique De Scheerder, et al.
Published: (2021)

51 HIV patients and caregivers viewpoints towards participation to future HIV cure-related clinical trials - results from the second part of the French ANRS-APSEC survey
by: C. Protière, et al.
Published: (2016)

From early AIDS vaccine to HIV cure research with analytical treatment interruption trials: a study participant testimonial
by: William Freshwater
Published: (2019)

Viral markers for HIV cure trials: are we getting any closer?
by: Ward De Spiegelaere
Published: (2016)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
by: Hursch Patel, et al.
Published: (2023)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
by: Eugène D.M.B. Kroon, et al.
Published: (2020)

Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands
by: Henrieke A.B. Prins, et al.
Published: (2020)

'Fear overcome by love': why I participated in HIV cure research
by: Clark Hawley
Published: (2018)

59 Interrupting HIV treatment in cure research: scientific and ethical considerations
by: S. Garner, et al.
Published: (2016)

A landscape analysis of HIV cure-related clinical trials and observational studies in 2018
by: Liz Barr, et al.
Published: (2019)

Barriers and facilitators of open contests to promote community engagement in HIV cure research: a qualitative evaluation among trial participants and community members
by: S. Day, et al.
Published: (2019)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017)

Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk
by: Karine Dubé, et al.
Published: (2024)

OP 3.5 - 00152 HIV-1RNA+infected CD4 T cell burden in acute HIV-1 infection and association with inflammatory markers
by: D. Bolton, et al.
Published: (2022)

The utility of the Connectivity Map (CMAP) for HIV cure strategies
by: Y.P. Gunawardana, et al.
Published: (2015)

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US
by: Karine Dubé, et al.
Published: (2017)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
by: Jillian SY. Lau, et al.
Published: (2021)

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
by: Yunda Huang, et al.
Published: (2022)

HIV cure is unachievable. The cons
by: Jean-Pierre Routy
Published: (2016)

Progress toward HIV cure
by: Daniel Kuritzkes
Published: (2016)

HIV cure is unachievable. The pros
by: Marie-Lise Gougeon
Published: (2016)